Zolpidem withdrawal induced uncoupling of GABAA receptors in vitro associated with altered GABAA receptor subunit mRNA expression

Acta Neurobiologiae Experimentalis

Volumn 75, Issue 2, 2015, Pages 160-171

  Jembrek, Maja Jazvinšćak ^a,b   Vlainić, Josipa ^a   Šuran, Jelena ^c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b Croatian Academy of Medical Sciences Zagreb   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Chronic treatment; GABAA receptors; Ligand binding; mRNA; Uncoupling; Withdrawal; Zolpidem

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; MESSENGER RNA; PYRIDINE DERIVATIVE; ZOLPIDEM;

BINDING SITE; DRUG EFFECTS; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; UPREGULATION;

BENZODIAZEPINES; BINDING SITES; HEK293 CELLS; HUMANS; HYPNOTICS AND SEDATIVES; PYRIDINES; RECEPTORS, GABA-A; RNA, MESSENGER; UP-REGULATION;

EID: 84937676179     PISSN: 00651400     EISSN: 16890035     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Ali NJ, Olsen RW (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79: 1100-1108.
2. Auta J, Impagnatiello F, Kadriu B, Guidotti A, Costa E (2008) Imidazenil: a low efficacy agonist at alpha1-but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem. Neuropharmacology 55: 148-153.
3. Bateson AN (2002) Basic pharmacological mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8: 5-21.
4. Besnard F, Even Y, Itier V, Granger P, Partiséti M, Avenet P, Depoortere H, Graham D (1997) Development of stable cell lines expressing different subtypes of GABAA receptors. J Recept Signal Transduct Res 17: 99-113.
5. Biggio G, Dazzi L, Biggio F, Mancuso L, Talani G, Busonero F, Mostallino MC, Sanna E, Follesa P (2003) Molecular mechanisms of tolerance to and withdrawal of GABA(A) receptor modulators. Eur Neuropsychopharmacol 13: 411-423.
6. Crestani F, Martin JR, Mohler H, Rudolph (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131: 1251-1254.
7. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G (1986) Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 237: 649-658.
8. Fitzgerald AC, Wright BT, Heldt SA (2014) The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors. Psychopharmacology (Berl) 231: 1865-1896.
9. Follesa P, Mancuso L, Biggio F, Cagetti E, Franco M, Trapani G, Biggio G (2002) Changes in GABAA receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem. Neuropharmacology 42: 191-198.
10. Fradley RL, Guscott MR, Bull S, Hallett DJ, Goodacre SC, Wafford KA (2007) Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands. J Psychopharmacol 21: 384-391.
11. Gallager DW, Lakoski JM, Gonsalves SF, Rauch SL (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308: 74-77.
12. Galpern WR, Lumpkin M, Greenblatt DJ, Shader RI, Miller LG (1991) Chronic benzodiazepine administration. VII. Behavioral tolerance and withdrawal and receptor alterations associated with clonazepam administration. Psychopharmacol (Berl) 104: 225-230.
13. Gravielle MC, Faris R, Russek SJ, Farb DH (2005) GABA induces activity dependent delayed-onset uncoupling of GABA/benzodiazepine site interactions in neocortical neurons. J Biol Chem 280: 20954-20960.
14. Gutiérrez ML, Ferreri MC, Gravielle MC (2014) GABAinduced uncoupling of GABA/benzodiazepine site interactions is mediated by increased GABAA receptor internalization and associated with a change in subunit composition. Neuroscience 257: 119-129.
15. Holt RA, Bateson AN, Martin IL (1997) Chronic zolpidem treatment alters GABA(A) receptor mRNA levels in the rat cortex. Eur J Pharmacol 329: 129-132.
16. Itier V, Granger P, Perrault G, Depoortere H, Scatton B, Avenet P (1996) Protracted treatment with diazepam reduces benzodiazepine1 receptor-mediated potentiation of gamma-aminobutyric acid-induced currents in dissociated rat hippocampal neurons. J Pharmacol Exp Ther 279: 1092-1099.
17. Jazvinscak Jembrek M, Svob Strac D, Vlainic J, Pericic D (2008) The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res 61: 234-241.
18. Jazvinscak Jembrek M, Cipak Gasparovic A, Vukovic L, Vlainic J, Zarković N, Orsolic N (2012) Quercetin supplementation: insight into the potentially harmful outcomes of neurodegenerative prevention. Naunyn Schmiedebergs Arch Pharmacol 385: 1185-1197.
19. Kang I, Lindquist DG, Kinane B, Ercolani L, Pritchard GA, Miller LG (1994) Isolation and characterization of the promoter of the human GABAA receptor α1 subunit gene. J Neurochem 62: 1643-1646.
20. Klein RL, Whiting PJ, Harris RA (1994) Benzodiazepine treatment causes uncoupling of recombinant GABAA receptors expressed in stably transfected cells. J Neurochem 63: 2349-2352.
21. Klein RL, Mascia MP, Harkness PC, Hadingham KL, Whiting PJ, Harris RA (1995) Regulation of allosteric coupling and function of stably expressed γ-aminobutyric acid (GABA)A receptors by chronic treatment with GABAA and benzodiazepine agonists. J Pharmacol Exp Ther 274: 1484-1492.
22. Korpi ER, Grunder G, Lüddens H (2002) Drug interactions at GABA(A) receptors. Prog Neurobiol 67: 113-159.
23. Lewin E, Peris J, Bleck V, Zahniser NR, Harris RA (1989) Diazepam sensitizes mice to FG 7142 and reduces muscimol-stimulated 36Cl-flux. Pharmacol Biochem Behav 33: 465-468.
24. Lilly SM, Zeng XJ, Tietz EI (2003) Role of protein kinase A in GABAA receptor dysfunction in CA1 pyramidal cells following chronic benzodiazepine treatment. J Neurochem 85: 988-998.
25. Murphy HM, Ihekoronze C, Wideman CH (2011) Zolpideminduced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav 98: 81-86.
26. Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Pharmacol Rev 60: 243-260.
27. Pericic D, Jazvinscak Jembrek M, Svob Strac D, Lazic J, Spoljaric IR (2005) Enhancement of benzodiazepine binding sites following chronic treatment with flumazenil. Eur J Pharmacol 507: 7-13.
28. Pericic D, Svob Strac D, Jazvinscak Jembrek M, Vlainic J (2007) Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA(A) receptors. Naunyn Schmiedebergs Arch Pharmacol 375: 177-187.
29. Pericic D, Vlainic J, Svob Strac D (2008) Sedative and anticonvulsant effects of zolpidem in adult and aged mice. J Neural Transm 115: 795-802.
30. Primus RJ, Yu J, Xu J, Hartnett C, Meyyappan M, Kostas C, Ramabhadran TV, Gallager DW (1996) Allosteric uncoupling after chronic benzodiazepine exposure of recombinant γ-aminobutyric acidA receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity. J Pharmacol Exp Ther 276: 882-890.
31. Roca DJ, Schiller GD, Friedman L, Rozenberg I, Gibbs TT, Farb DH (1990) γ-Aminobutyric acidA receptor regulation in culture: altered allosteric interactions following prolonged exposure to benzodiazepines, barbiturates, and methylxanthines. Mol Pharmacol 37: 710-719.
32. Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Möhler H (1999) Benzodiazepine actions mediated by specific gammaaminobutyric acid(A) receptor subtypes. Nature 401: 796-800.
33. Sanger DJ, Zivkovic B (1986) The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic. Psychopharmacol (Berl) 89: 317-322.
34. Sanger DJ, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 313: 35-42.
35. Sanna E, Busonero F, Talani G, Carta M, Massa F, Peis M, Maciocco E, Biggio G (2002) Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes. Eur J Pharmacol 451: 103-110.
36. Shaw G, Morse S, Ararat M, Graham FL (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J 16: 869-871.
37. Svob Strac D, Vlainic J, Jazvinscak Jembrek M, Pericic D (2008) Differential effects of diazepam treatment and withdrawal on recombinant GABAA receptor expression and functional coupling. Brain Res 1246: 29-40.
38. Toki S, Saito T, Hatta S, Takahata N (1996) Diazepam physical dependence and withdrawal in rats is associated with alteration in GABAA receptor function. Life Sci 59: 1631-1641.
39. Uusi-Oukari M, Heikkilä J, Sinkkonen ST, Mäkelä R, Hauer B, Homanics GE, Sieghart W, Wisden W, Korpi ER (2000) Long-range interactions in neuronal gene expression: evidence from gene targeting in the GABAA receptor β2-α6-α1-γ2 subunit gene cluster. Mol Cell Neurosci 16: 34-41.
40. Uusi-Oukari M, Korpi ER (2010) Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev 62: 97-135.
41. Victorri-Vigneau C, Feuillet F, Wainstein L, Grall-Bronnec M, Pivette J, Chaslerie A, Sébille V, Jolliet P (2013) Pharmacoepidemiological characterisation of zolpidem and zopiclone usage. Eur J Clin Pharmacol 69: 1965-1972.
42. Vinkers C, Olivier B (2012) mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators? Adv Pharmacol Sci 2012: 416864.
43. Vlainic J, Pericic D (2009) Effect of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam. Neuropharmacology 56: 1124-1130.
44. Vlainic J, Pericic D (2010) Zolpidem is a potent anticonvulsant in adult and aged mice. Brain Res 1310: 181-188.
45. Vlainic J, Jazvinscak Jembrek M, Svob Strac D, Pericic D (2010) The effects of zolpidem treatment and withdrawal on the in vitro expression of recombinant alpha1beta2gamma2s GABA(A) receptors expressed in HEK 293 cells. Naunyn Schmiedebergs Arch Pharmacol 382: 201-212.
46. Vlainic J, Jembrek MJ, Vlainic T, Strac DS, Pericic D (2012a) Differential effects of short-and long-term zolpidem treatment on recombinant α1β2γ2s subtype of GABA(A) receptors in vitro. Acta Pharmacol Sin 33: 1469-1476.
47. Vlainic J, Svob Strac D, Jazvinscak Jembrek M, Vlainic T, Pericic D (2012b) The effects of zolpidem treatment on GABA(A) receptors in cultured cerebellar granule cells: changes in functional coupling. Life Sci 90: 889-894.
48. Wong G, Lyon T, Skolnick P (1994) Chronic exposure to benzodiazepine receptor ligands uncouples the gammaaminobutyric acid type A receptor in WSS-1 cells. Mol Pharmacol 46: 1056-1062.
49. A receptor mRNAs profile expression in mice: Comparison with diazepam. Psychopharmacol (Berl) 231: 1865-1896.